[11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy

Purpose Over the last decade, PET/CT with radiolabelled choline has been shown to be useful for restaging patients with prostate cancer (PCa) who develop biochemical failure. The limitations of most clinical studies have been poor validation of [11C]choline PET/CT-positive findings and lack of survival analysis. The aim of this study was to assess whether [11C]choline PET/CT can predict survival in hormone-naive PCa patients with biochemical failure.